Researchers at the University College London aim to understand the mechanisms underpinning visual hallucinations in both dementia with Lewy bodies (DLB) and Parkinson’s disease
Researchers from the University of Oxford will investigate how and why some people are ‘resilient’ to developing dementia to find new treatment targets.
Researchers at King’s College London are unpicking how mutations in specific proteins affect brain inflammation in frontotemporal dementia.
Researchers are looking at common pathways that affect our brain cells in frontotemporal dementia and motor neurone disease to find new drug targets
Dr Daniel Erskine from Newcastle University is investigating the role of a type of fat, called sphingolipids, in dementia with Lewy bodies.
Can boosting chemical messaging in the brain help people with early-stage dementia with Lewy bodies?
Researchers at Newcastle University will study how a drug affects people in early stages of dementia with Lewy bodies.
Understanding the role of metal particles in Alzheimer’s and their potential for diagnosis and treatment
Researchers at Keele University will develop ways to ‘see’ iron in the brain and explore how metals could be used as treatment targets and indicators of Alzheimer’s disease.
What happens when the barrier between blood vessels and brain cells breakdowns in Alzheimer’s disease?
Researchers are investigating whether the changes in cell metabolism at the barrier between blood vessels and brain cells contributes to brain degeneration.
Researchers are using powerful brain scanning techniques to investigate how sleep affects brain changes in people with Down’s syndrome (DS).
Researchers from the University of Cambridge will look at how enzymes and immune cells in the brain interact with the tau protein to cause disease